Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Test For Schizophrenia Using Antipsychotics and EEG
NCT03781115Phase 1Active, not recruiting
- Sponsor
- University of Arizona
- Start
- Nov 2017
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of ziprasidone and olanzapine in schizophrenia (3 arms), sponsored by University of Arizona. Primary endpoints: Heart Rate up to 2 years, Pulse Rate up to 2 years and 7 more. Started Nov 2017; status: active, not recruiting.
02
Drugs
ziprasidoneolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03781115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781115.